Translational Development Acquisition Corp.
TDAC
$10.17
-$0.01-0.10%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | -72.43% | 12,160.00% | 33.33% | 33.33% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -72.43% | 12,160.00% | 33.33% | 33.33% | |
| Operating Income | 72.43% | -12,160.00% | -33.33% | -33.33% | |
| Income Before Tax | 98.35% | -12,160.00% | -33.33% | -33.33% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 98.35% | -12,160.00% | -33.33% | -33.33% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 98.35% | -12,160.00% | -33.33% | -33.33% | |
| EBIT | 72.43% | -12,160.00% | -33.33% | -33.33% | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | 98.74% | -15,000.00% | -100.00% | -100.00% | |
| Normalized Basic EPS | 98.80% | -9,400.00% | 0.00% | 0.00% | |
| EPS Diluted | 98.74% | -15,000.00% | -100.00% | -100.00% | |
| Normalized Diluted EPS | 98.80% | -9,400.00% | 0.00% | 0.00% | |
| Average Basic Shares Outstanding | 33.82% | 0.00% | 0.00% | 0.00% | |
| Average Diluted Shares Outstanding | 33.82% | 0.00% | 0.00% | 0.00% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |